skip to main content
Back to Top

Last updated April 8, 2021

The COVID-19 Resource Canada Site

Funding opportunities


Aligning Science Across Parkinson’s (ASAP) – Collaborative Research Network

Pre-proposal deadline: December 11, 2020
Full application: 
April 13, 2021
​Funding ​Available: Up to $9,000,000 over three years, per team (additional funding available for pre-clinical models)

The ASAP initiative is accepting applications to support multidisciplinary research teams to join the newly established ASAP Collaborative Research Network. ASAP seeks to fund research projects that address key knowledge gaps in the basic mechanisms that contribute to Parkinson’s development and progression. Applications that focus primarily on circuitry and brain-body interactions, inclusive of genetic and neuro-immune contributors to disease, will be considered.

More information


The W. Garfield Weston Foundation Brain Health 2021: Lifestyle approaches and microbiome contributions

Letter of intent deadline: November 25, 2020
Proposal deadline: April 15, 2021
Funding available: Up to $1.5 million per project up to three years

The program seeks to increase the number of Canadians maintaining better brain health throughout their lives. This program aims to advance the treatment (e.g., symptomatic relief, disease modification) and/or prevention of neurodegenerative diseases of aging by accelerating the development and implementation of lifestyle approaches and/or identifying the contribution of the microbiome.

More information


CIHR | Health Research Training Platform

Registration deadline: April 21, 2021 Application deadline: June 22, 2021
Funding available: The total amount available for this funding opportunity is $28,800,000 enough to fund approximately 12 grants. The maximum amount per grant is $400,000 per year for up to 6 years, for a total of $2,400,000 per grant.

The Health Research Training Platform (HRTP) Pilot funding opportunity is intended to support the development of interdisciplinary, inter-jurisdictional, and intersectoral research training platforms that will attract a diverse cadre of high-caliber trainees and ECRs, and equip them with the skills required for academic and non-academic careers. These research training platform grants can be used to build capacity in established or emerging areas, within the scope of the research training areas including: digital solutions for seniors with complex health needs; boys, men and masculinity; drug safety and effectiveness, AI, public health and equity, girls and women’s health and wellness; human development, child and youth; improving health outcomes through better models of care for multimorbidity; integrating mental health services within primary and community care; nutrition, metabolism and diabetes; stigma reduction and life course mental wellness for LGBTQ/2S populations; and vascular cognitive impairment.

More information


AMS: Small grants

Information teleconference call: April 21, 2021, 1 p.m. ET
Application deadline: June 3, 2021, 5 p.m. ET
Funding available: $20,000

AMS Healthcare is offering grants of up to $20,000 to early and mid-career academic researchers and regulated health care professionals to support research, knowledge translation and spread and scale activities related to the impact of DT/AI on compassionate care.

More information
Funding call


Alzheimer’s Drug Discovery Foundation-Harrington Scholar Program

LOI deadline: April 23, 2021, 5 p.m. ET
Proposal deadline: July 30, 2021, 5 p.m. ET
Funding available: $600,000 over two years

The ADDF-Harrington Scholar Program is dedicated to advancing academic discoveries into medicines for Alzheimer’s disease and related dementias. This unique award provides funding and committed project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute.

More information


AGE-WELL Emerging entrepreneur award in technology and aging

Application deadline: April 30, 2021
Funding available: $25,000

The AGE-WELL Emerging Entrepreneur Award supports the development of emerging entrepreneurs to create and grow an innovative start-up with potential social and economic impact in Canada. The innovation must address one of AGE-WELL’s 8 Challenge Areas to shape the future of technology and aging research in Canada. This award is designed to give a new entrepreneur the financial resources to focus on making their ideas viable and rapidly deployable in service to our stakeholders.

More information


NSERC | Collaborative Research and Training Experience (CREATE)

Letter of intent deadline: May 1, 2021
Application deadline: September 22, 2021
Funding available: Up to $150,000 in the first year and up to $300,000 for up to five subsequent years, for a maximum of $1.65M over 6 years.

The CREATE program supports the training and mentoring of teams of highly qualified students and postdoctoral fellows from Canada and abroad through the development of innovative training programs that encourage collaborative and integrative approaches, and address significant scientific challenges associated with Canada’s research priorities and facilitate the transition of new researchers from trainees to productive employees in the Canadian workforce. These innovative programs must foster the acquisition and development of important professional skills among students and postdoctoral fellows that complement their qualifications and technical skills, and improve their job readiness for careers in industry, government, non-governmental organizations and/or academia.

More information


NIH Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Application deadline: May 7, 2021
Funding available: See award

More information


NIH Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Application deadline: May 7, 2021
Funding available: See award

More information


NIH | Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed)

Letter of intent deadline: May 15, 2021
Application deadline: June 15, 2021
Funding available: NIA intends to commit $3 million in FY 2022 to fund 5-6 awards. Application budgets are limited to $300,000 in direct costs per year. Budget requests must reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.

This funding opportunity seeks to support studies on normal and pathobiological changes in aging bone marrow that impact, or are impacted by, changes in immune function with age. Studies to be supported are in the field of osteoimmunology, which concerns the bidirectional interactions between bone and the immune system. The objective of this RFA is to support research that will illuminate the bidirectional interactions between aging bone and the aging immune system.

More information


NIH | The Cellular Scale Connectome in Aging and Alzheimer’s Disease (U01 Clinical Trial Not Allowed)

Letter of intent deadline: May 15, 2021
Application deadline: June 15, 2021
Funding available: Application budgets are not limited but need to reflect the actual needs of the
proposed project (total available is $8.0 million in to fund 3-5 awards).

This funding opportunity announcement invites applications that will: (1) promote the development of a comprehensive characterization of brain circuits susceptible to Alzheimer’s disease type pathology and/or neurodegeneration in mouse models of Alzheimer's disease (AD), (2) share data on the cell connectome in the aging and AD brain in a common reference brain cell atlas that integrates both molecular and anatomical annotations, and (3) complement and extend research on vulnerable cell types to include the mapping of connectivity changes between cells in aging and AD and provide a greater understanding of the mechanisms underlying resilience and vulnerability in AD.

More information


NIH | New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed)

Letter of intent deadline: May 17, 2021
Application deadline: June 17, 2021
Funding available: Application budgets are limited to $500,000 in annual direct costs (total available is
$6,400,000 to fund 8 to 10 awards).

The goal of this funding opportunity announcement is to support research on novel approaches and/or innovative expansion of existing approaches to identify the presence of neurogenesis and study its dynamics in brain aging and Alzheimer’s disease and its related dementias.

More information


Active and Assisted Living Programme Call for Proposals 2021: Advancing inclusive health & care solutions for ageing well in the new decade

Application deadline: May 21, 2021
Funding available: Collaborative projects (carried out by consortia composed of at least 3 organizations from 3 different countries including an end user organization and a business partner) will remain the main funding tool for this call. This type of projects has a duration of 12 to 30 months with a maximum funding of €2.500.000. Small collaborative projects have a duration of 6 to 9 months, the same central eligibility criteria as the Collaborative projects, a maximum co-funding budget of €300.000 and leaner application and reporting procedures.

Digital solutions in health and care can support the well-being of older adults in many areas of their daily lives at home and in their communities. They can also support care professionals and informal careers and help tap into the labour potential of active and healthy older people. While keeping an open call approach, the call 2021 would like to stress an inclusive health and care approach (health prevention, preservation of physical and mental health, social participation), the stimulation and upscaling of innovation in active and healthy aging through health and care eco-systems and the accessibility of digital solutions to end users, e.g., through education for greater e-literacy.

More information


Alzheimer’s Drug Discovery Foundation Neuroimaging and CSF Biomarker Development Program

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: $600,000 over 1 year (multi year proposals considered)

The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Specifically, this RFP focuses on developing novel PET ligands for clinical trials, supporting novel CSF biomarkers, validating established MRI approaches in larger cohorts.

More information


Alzheimer’s Drug Discovery Foundation Drug Development Program

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: Up to $600,000 based on stage and scope of research, per year. One year with potential for follow-on funding. Multi-year proposals can be considered.

The Drug Development RFP seeks to support in vivo preclinical studies that advance lead molecules developed for Alzheimer’s disease and related dementias to IND-enabling studies. The proposed studies should be structured to deliver a compound with strong potential for clinical and commercial application. This funding opportunity prioritizes novel drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP. 

More information


Alzheimer’s Drug Discovery Foundation Program to Accelerate Clinical Trials (PACT)

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: Up to $3,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment. Average duration multi-year, with potential for follow-on funding.

The PACT RFP supports IND-enabling studies and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias. Both disease-modifying and symptomatic agents will be considered. This funding opportunity prioritizes diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP. 

More information


Alzheimer's Drug Discovery Foundation Prevention Pipeline

Letter of intent deadline: February 5, 2021; May 28, 2021; October 1, 2021
Funding available: $3,000,000 (multi year proposal)

The Alzheimer’s Drug Discovery Foundation seeks to support studies of cognitive symptoms due to health conditions, comparative effectiveness research, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. The Prevention Pipeline supports: studies of cognitive decline and risk reduction, comparative effectiveness research, studies leveraging the consortium of cohorts for Alzheimer's prevention action.

More information


Retired Teachers of Ontario | Giving back to our communities

Application deadline: June 1, 2021
Funding available: Up to $2500

Community Grants are designed to encourage all RTOERO Districts to support and partner with local organizations to promote projects that will help our organization to meet our strategic goals of improving the lives of members and seniors; being the trusted voice for the broader education communities; and broadening our membership base. Since the inception of this grant 21 years ago, we’ve donated $1.85 million for 523 projects. This year RTOERO Districts are eligible to receive grants of up to $2,500 for community projects that advance these strategic goals. Districts interested will serve as the project sponsor and will submit the application for a Community Grant in partnership with a community organization.

More information


CIHR | Team Grant: Indigenous Healthy Life Trajectories Initiative Cohort Research Study (I-HeLTI)

Application deadline: June 9, 2021
Funding available: The total amount available for this funding opportunity is $14,100,000

More information


CIHR | Team Grant: Diabetes Mechanisms and Translational Solutions

Application deadline: July 13, 2021
Funding available: The maximum amount per grant is $400,000 per year for up to 5 years, for a total up to of $2,000,000 per grant.

As part of 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes, the Team Grants in Diabetes Mechanisms and Translational Solutions will support multi-disciplinary research to better understand the underlying causes and pathophysiology of diabetes and develop improved prevention and treatment approaches for diabetes. For the purposes of this Initiative, diabetes includes all forms of diabetes mellitus, its complications, and co-morbidities. Mechanistic research is defined as studies designed to understand the pathophysiology of diabetes, its complications, and co-morbidities. Translational research is defined as research that advances effective translation and application of knowledge across the expanse of pre-clinical, clinical and health services delivery domains to improve patient outcomes.

More information


CIHR Institute of Aging| Planning and Dissemination Grants

Application deadline: December 13, 2021
Funding available: The maximum amount awarded for a single grant is $25,000.

More information


Birks Family Foundation Grant

Application deadline: Rolling (apply six months prior to when funds would be required) 
Funding available: Application dependent

The Birks Family Foundation funds organizations either primarily focused on Quebec, or those whose work is broadly national in nature; Public sector organizations, including universities, hospitals, libraries and museums; Projects that demonstrate unique innovation in their field and/or pioneer state-of-the-art technology; Long range projects designed to become self-sustaining; and, organizations that actively engage directly with their target group through programs and/or services. 

More information


Max Bell Foundation Grant

Application deadline: Rolling
Funding details: Apply for the amount of money that you need to complete your project. Be aware that Max Bell Foundations generally funds 30-60% of a project and prefers to fund projects that have other funders.

The foundation prefers to collaborate with applicants to create final project proposals. Proposals should focus on development of forward-looking innovations that impact public policies and practices with an emphasis on health and wellness, education, and the environment.

More information


NSERC Alliance

Application deadline: applications are currently being accepted for Option 1 and 2
Funding available: $20,000 to $1,000,000 per year for one to five years

NSERC Alliance grants encourage university researchers to collaborate with partner organizations, which can be from the private, public or not-for-profit sectors. Funding may support research and development projects that seek to respond to a research challenge in the natural sciences or engineering, while working with external partners who are able to accelerate scale-up, application, impact, or commercialization. NSERC is now accepting Option 1 applications requiring at least 50 per cent matching cash contributions from partner organizations, and for Option 2, involving non-profit partners and requesting 90 to 100 per cent funding support from NSERC.

More information


Physician’s Services Incorporated (PSI) Foundation 

Clinical Research Grant

The PSI Clinical Research Grant is open to Post M.D. physicians looking to conduct research which is of direct relevance to patient care.

More information

Health Systems Research Grant

The Health Systems research grant funds projects of a special nature within the healthcare system, such as preventative medicine, care of the elderly, communications within the system, underserviced regions, and ways of enhancing the effectiveness of medical practice will be considered under this category. 

More information

New Investigator Research Grant 

The New Investigator funding stream is open to Clinical Fellows or physicians within five years of their first academic appointment. 

More information

Resident Research Grant 

Resident Research Grants are concise health research projects, which have been largely developed by the Resident. To be eligible to apply for a Resident Research Grant, the Resident must have PGY status as per the College of Physicians and Surgeons of Ontario. The restriction whereby PSI will not consider applications for research within the areas of cancer, and heart and stroke does not apply to resident research projects.

More information

Healthcare Research by Community Physicians Grant 

To assist physicians practicing in a community setting to undertake a review of their practice patterns which would enhance effectiveness of practice and patient care in their own clinic, hospital, or region.

More information

Graham Farquharson Knowledge Translation Fellowship 

The PSI Graham Farquharson Fellowship is intended to provide salary support for a new investigator who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research.

More information

 
 
Email MIRA at: MIRAinfo@mcmaster.ca       Follow us on Twitter : @MIRAMcMaster
McMaster Footer Logo
Institute For Research On Aging Footer Logo

© 201​6 McMaster University  |  MIP Suite 109A, 1280 Main St. W., Hamilton, ON L8S 4K1  |  Contact Us  | Email UsTerms of Use & Privacy Policy